<?xml version="1.0" encoding="UTF-8"?>
<fig id="Fig3">
 <label>Fig. 3</label>
 <caption>
  <p>Representative immunostaining of ENO1 in primary and metastatic tumors. 
   <bold>a</bold>, 
   <bold>b</bold>, 
   <bold>e</bold>, 
   <bold>f</bold>, 
   <bold>i</bold>, and 
   <bold>j</bold> show primary tumors. 
   <bold>c</bold>, 
   <bold>d</bold>, 
   <bold>g</bold>, 
   <bold>h</bold>, 
   <bold>k</bold>, and 
   <bold>l</bold> show metastatic tumors. 
   <bold>a</bold>, 
   <bold>e</bold>, 
   <bold>i</bold>, 
   <bold>c</bold>, 
   <bold>g</bold>, and 
   <bold>k</bold> show HE staining. 
   <bold>b</bold>, 
   <bold>f</bold>, 
   <bold>j</bold>, 
   <bold>d</bold>, 
   <bold>h</bold>, and 
   <bold>l</bold> show ENO1 staining. ENO1 is overexpressed in metastatic tumors. All images are ×400 magnification. 
   <italic>Scale bars</italic> 100 mm. 
   <italic>EC</italic> endometrial cancer (
   <bold>a</bold>–
   <bold>d</bold>). 
   <italic>CeC</italic> Uterine cervical cancer (
   <bold>e</bold>–
   <bold>h</bold>). 
   <italic>OC</italic> ovarian cancer (
   <bold>i</bold>–
   <bold>l</bold>)
  </p>
 </caption>
 <graphic xlink:href="13577_2012_53_Fig3_HTML" id="MO3" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
